1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Admission demographics, site of occlusion, and workflow metrics
Variables Total (n = 72 Patients)
Age (median) (minimum-maximum) (yr) 68 (32–89)
Men (No.) (%) 37 (51.4)
Stroke on awakening (No.) (%) 27 (46.6)
Site of occlusion (No.) (%)  
 MCA 29 (40.3)
 ACA 3 (4.0)
 ICA 16 (22.2)
 Tandem 5 (6.9)
Affected hemisphere (No.) (%)  
 Right 30 (41.7)
 Left 39 (54.2)
Coronary artery disease (No.) (%) 12 (16.7)
Congestive heart failure (No.) (%) 6 (8.3)
Valvular disease (No.) (%) 2 (3.4)
Hypertension (No.) (%) 38 (52.8)
Dyslipidemia (No.) (%) 24 (33.3)
Diabetes (No.) (%) 1 (1.4)
Smoking (No.) (%) 20 (27.8)
Statin (No.) (%) 22 (37.9)
EVT treatment (No.) (%) 72 (100)
tPA (alteplase) treatment (No.) (%) 55 (76)
Reperfusion (TICI 2b/3) (No.) (%) 72 (100)
Blood glucose (median) (minimum-maximum) (mmol) 6 (4.4–20.0)
NIHSS baseline (median) (minimum-maximum) 17 (1–29)
NIHSS 24 hours (median) (minimum-maximum) 6 (0–24)
MR spectroscopy baseline (median) (minimum-maximum) 0 (0–3)
MR spectroscopy (median) (minimum-maximum) (90 days) 2 (0–6)
CT to reperfusion time (median) (minimum-maximum) (hh:mm) 1:28 (0:27–3:06)
Note:—hh:mm indicates hours: minutes; ACA, anterior cerebral artery.